	Impact of Non-steroidal Anti-inflammatory Drugs on Recurrence and Survival after Melanoma Surgery: A Cohort Study. Cancer Invest Araujo BLC, de Oliveira JL, Rezende JFN, Noguera WS, de Melo AC, Thuler LCS. PMID: 32643437 [PubMed - as supplied by publisher]
	Oncology Nurse Coordinators in Clinical Trials - Shaking up the Melanoma Team. Asia Pac J Oncol Nurs Steinberg H. PMID: 32642495 [PubMed]
	Acral Lentiginous Melanoma: A Rare Variant With Unique Diagnostic Challenges. Cureus Brazen BC, Gray T, Farsi M, Miller R. PMID: 32642340 [PubMed]
	Melanoma Epidemiology and Early Detection in Europe: Diversity and Disparities. Dermatol Pract Concept Forsea AM. PMID: 32642304 [PubMed]
	T-cell receptor therapy (TCR) against melanoma -immunotherapy for the future? Scand J Immunol Winge-Main AK, Wälchli S, Marit Inderberg E. PMID: 32640053 [PubMed - as supplied by publisher]
	Immunotherapy discontinuation - how, and when? Data from melanoma as a paradigm. Nat Rev Clin Oncol Robert C, Marabelle A, Herrscher H, Caramella C, Rouby P, Fizazi K, Besse B. PMID: 32636502 [PubMed - as supplied by publisher]
	Reporting regression with melanoma in situ: reappraisal of a potential paradox. Arch Dermatol Res Cartron AM, Aldana PC, Khachemoune A. PMID: 32632620 [PubMed - as supplied by publisher]
	Consensus Guidelines for the Management of Melanoma during the COVID-19 Pandemic: Surgery, Systemic Anti-cancer Therapy, Radiotherapy and Follow-up. Clin Oncol (R Coll Radiol) Nahm SH, Rembielak A, Peach H, Lorigan PC, Contributing Clinicians.. PMID: 32631767 [PubMed - as supplied by publisher]
	Cell-Mediated Release of Nanoparticles as a Preferential Option for Future Treatment of Melanoma. Cancers (Basel) Chillà A, Margheri F, Biagioni A, Del Rosso T, Fibbi G, Del Rosso M, Laurenzana A. PMID: 32630815 [PubMed]
	Chitosan-Based Delivery of Avian Reovirus Fusogenic Protein p10 Gene: In Vitro and In Vivo Studies towards a New Vaccine against Melanoma. Biomed Res Int Robles-Planells C, Barrera-Avalos C, Rojo LE, Spencer E, Cortez-San Martin M, Matiacevich S, Pavez J, Milla LA, Navarro FD, Martínez BA, Bravo FJ, Mella A, Huidobro-Toro JP, Fernandez R, Escobar A, Castillo CA. PMID: 32626742 [PubMed - in process]
	Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma. Front Cell Dev Biol Yeon M, Kim Y, Jung HS, Jeoung D. PMID: 32626712 [PubMed]
	The MelFo Study UK: Effects of a Reduced-Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma 1B to 2C Patients After 3-Years. Ann Surg Oncol Moncrieff MD, Underwood B, Garioch JJ, Heaton M, Patel N, Bastiaannet E, Hoekstra-Weebers JEHM, Hoekstra HJ. PMID: 32623608 [PubMed - as supplied by publisher]
	A Retrospective Multicenter Study of Fatal Pediatric Melanoma. J Am Acad Dermatol Hawryluk EB, Moustafa D, Bartenstein D, Brahmbhatt M, Cordoro K, Gardner L, Gauthier A, Grossman D, Gupta D, Hunt RD, Jen M, Kao PC, Kruse LL, Lawley LP, London WB, Mansour D, O'Haver JA, Phung T, Pope E, Price HN, Rogers T, Shah SD, Wolner Z, Huang J, Marghoob AA. PMID: 32622142 [PubMed - as supplied by publisher]
	Early Phase of Primary Melanoma Growth from the Patient Point of view: A Prospective Cross Sectional Study on Melanoma over 1 mm in Thickness. Acta Derm Venereol Malissen N, Abed S, Macagno N, Amatore F, Loundou A, Grange F, Gaudy-Marqueste C, Grob JJ. PMID: 32618351 [PubMed - as supplied by publisher]
	Optimal treatment strategy for metastatic melanoma patients harboring BRAF-V600 mutations. Ther Adv Med Oncol Giunta EF, De Falco V, Napolitano S, Argenziano G, Brancaccio G, Moscarella E, Ciardiello D, Ciardiello F, Troiani T. PMID: 32612709 [PubMed]
	Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover. Cancers (Basel) Lebbé C, Dutriaux C, Lesimple T, Kruit W, Kerger J, Thomas L, Guillot B, Braud F, Garbe C, Grob JJ, Loquai C, Ferraresi V, Robert C, Vasey P, Conry R, Isaacs R, Espinosa E, Schueler A, Massimini G, Dréno B. PMID: 32610581 [PubMed]
	Characterization of uveal melanoma clinical trial design: a systematic review to establish an elusive standard of care. Acta Oncol Zhang HG, Moser JC, Dalvin LA. PMID: 32609032 [PubMed - as supplied by publisher]
	Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: a population-based case-control study. Basic Clin Pharmacol Toxicol Daniels B, Pearson SA, Vajdic CM, Pottegård A, Buckley NA, Zoega H. PMID: 32608576 [PubMed - as supplied by publisher]
	KIT and Melanoma: Biological Insights and Clinical Implications. Yonsei Med J Pham DDM, Guhan S, Tsao H. PMID: 32608199 [PubMed - in process]
	Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study. J Immunother Cancer Kobayashi T, Iwama S, Yasuda Y, Okada N, Okuji T, Ito M, Onoue T, Goto M, Sugiyama M, Tsunekawa T, Takagi H, Hagiwara D, Ito Y, Suga H, Banno R, Yokota K, Hase T, Morise M, Hashimoto N, Ando M, Fujimoto Y, Hibi H, Sone M, Ando Y, Akiyama M, Hasegawa Y, Arima H. PMID: 32606047 [PubMed - in process]

Articles 1 - 20 / 106867

Page 1 of 5344



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy